Related references
Note: Only part of the references are listed.Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
Diego O. Croci et al.
CELL (2014)
Nuclear transport of galectin-3 and its therapeutic implications
Tatsuyoshi Funasaka et al.
SEMINARS IN CANCER BIOLOGY (2014)
Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages
Camila Maria Longo Machado et al.
CANCER MEDICINE (2014)
Galectin-3 Accelerates M2 Macrophage Infiltration and Angiogenesis in Tumors
Weizhen Jia et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling
Umadeui V. Wesley et al.
BRAIN RESEARCH (2013)
Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases
Pratima Nangia-Makker et al.
CANCER BIOLOGY & THERAPY (2013)
Increased Circulation of Galectin-3 in Cancer Induces Secretion of Metastasis-Promoting Cytokines from Blood Vascular Endothelium
Chen Chen et al.
CLINICAL CANCER RESEARCH (2013)
VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1-and Galectin-3-Induced Angiogenesis
Nicky D'Haene et al.
PLOS ONE (2013)
The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma
Ling Xie et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
The Two Endocytic Pathways Mediated by the Carbohydrate Recognition Domain and Regulated by the Collagen-like Domain of Galectin-3 in Vascular Endothelial Cells
Xiaoge Gao et al.
PLOS ONE (2012)
Galectin-3-A jack-of-all-trades in cancer
Anna U. Newlaczyl et al.
CANCER LETTERS (2011)
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
Shigeru Tsuboi et al.
EMBO JOURNAL (2011)
Tumor exploits alternative strategies to achieve vascularization
Benedetta Bussolati et al.
FASEB JOURNAL (2011)
Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells
Anna I. Markowska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Galectin-3 Enhances Proliferation and Angiogenesis of Endothelial Cells Differentiated from Bone Marrow Mesenchymal Stem Cells
S. Y. Wan et al.
TRANSPLANTATION PROCEEDINGS (2011)
Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer
Pratima Nangia-Makker et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
Anna I. Markowska et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Angiogenesis in pre-malignant conditions
Marius Raica et al.
EUROPEAN JOURNAL OF CANCER (2009)
Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice
Isabelle Eude-Le Parco et al.
GLYCOBIOLOGY (2009)
Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on α3β1 integrin
Chandrassegar Saravanan et al.
JOURNAL OF CELL SCIENCE (2009)
The galectin profile of the endothelium - Altered expression and localization in activated and tumor endothelial cells
Victor L. Thijssen et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas
Nicky D'Haene et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Regulation of Tumor Progression by Extracellular Galectin-3
Pratima Nangia-Makker et al.
CANCER MICROENVIRONMENT (2008)
Galectin-3 cleavage: A novel surrogate marker for matrix metalloproteinase activity in growing breast cancers
Pratima Nangia-Makker et al.
CANCER RESEARCH (2007)
Tumour vascularization: sprouting angiogenesis and beyond
Femke Hillen et al.
CANCER AND METASTASIS REVIEWS (2007)
Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3
Eunju Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis
GA Rabinovich et al.
GLYCOBIOLOGY (2006)
Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death
BN Stillman et al.
JOURNAL OF IMMUNOLOGY (2006)
Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes
N Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and α3β1 integrin
J Fukushi et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Alterations in galectin-3 expression and distribution correlate with breast cancer progression - Functional analysis of galectin-3 in breast epithelial-endothefial interactions
MPV Shekhar et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin
P Nangia-Makker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Galectin-3 and metastasis
Y Takenaka et al.
GLYCOCONJUGATE JOURNAL (2002)
The microenvironment of the tumour-host interface
LA Liotta et al.
NATURE (2001)
Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin 3
C Hikita et al.
JOURNAL OF CELL BIOLOGY (2000)
Galectin-3 induces endothetial cell morphogenesis and angiogenesis
P Nangia-Makker et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
